[Congressional Record Volume 141, Number 80 (Monday, May 15, 1995)]
[Senate]
[Page S6700]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]


                    HONORING DR. JAN MOOR-JANKOWSKI

 Mr. D'AMATO. Mr. President, at this time I would like to pay 
tribute to an outstanding professor at New York University by the name 
of Jan Moor-Jankowski. Dr. Moor-Jankowski, a world renowned research 
physician and trailblazer on scientific first amendment rights, has 
been unanimously elected to the late Dr. Linus Pauling's chair at the 
French National Academy of Medicine, Division of Biologic Sciences.
  The origins of the French Academy of Medicine extend to the Royal 
Academies of the 18th century. The Academy provides a forum for medical 
debates and advises the French Government on health-related matters. 
Louis Pasteur was one of its notable members. A limited number of 
distinguished non-French scientists are elected to provide 
representation of the world-wide scientific community. An election is 
for lifetime and only occurs when a chair is vacated.
  Election to the Academy is one of France's highest and rarest honors, 
reserved for the most respected scientist in the world. At the time of 
his election, Nobel Prize winner Dr. Pauling was virtually a household 
name thanks to his groundbreaking theories on the effects of vitamins 
on cancer and other diseases. Like Dr. Pauling, Dr. Moor-Jankowski was 
chosen from a list of highly regarded candidates as the sole U.S. 
citizen to be honored with membership on the biological sciences board 
of the Academy.
  For example, this latest award is only the last in a string of 
scientific honors bestowed on Dr. Moor-Jankowski. In 1994, he was given 
the William J. Brennan, Jr. Defense of Freedom Award by the Libel 
Defense Resource Center. In addition, in 1984, Dr. Moor-Jankowski was 
made a Knight of the French Order ``Ordre National de Merite'' for 
World War II resistance and scientific achievements. Other medals and 
awards from Israel, the U.S.S.R., Italy, and Switzerland have 
punctuated his career.
  Dr. Moor-Jankowski is an alumnus of the Swiss universities of 
Fribourg and Berne. He began his career at the University of Geneva 
where his research interests in the study of polymorphic phenotypic 
expressions of the genetic substrate of man led to his discovery of 
clinically silent hemophilia B, and of the significant genetic drift of 
blood group frequencies in the inhabitants of the highest Alpine 
villages. During subsequent research at Cambridge University, Dr. Moor-
Jankowski discovered the polymorphism of allotypes of serum proteins in 
mice and monkeys.
  For the past 30 years, Dr. Moor-Jankowski's laboratory, LEMSIP, has 
been participating in international collaborative studies leading to 
the development of the first tests for and vaccines against various 
forms of infectious hepatitis, and since 1987, in collaboration with 
Institute Pasteur, Paris, in the development of the first vaccines 
against AIDS.
  He also serves as Director of the World Health Organization 
Collaborating Center for Hematology of Primate Animals, and is editor-
in-chief of the Journal of Medical Primatology.
  Again I would like to take this time to honor an outstanding New York 
resident who has devoted his life to enhancing the quality of life in 
this country and toward solving world health problems. We wish him 
continued success in all future endeavors.


                          ____________________